COVID-19 Self-Test Kit Distributed Without Clinical Investigation Authorization
Innova Medical Group recalled COVID-19 self-test kits distributed to customers outside of clinical investigation requirements. About 1,206 tests in 402 boxes were distributed across the U.S., Canada, India, and the United Kingdom.
The agency’s classification
FDA (Devices): Class I
Class I is a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: FDA Class I classification mandates a minimum severity score of 4 per the rubric. Although no product defect or user injury is reported, the unauthorized distribution of an unvalidated medical device violates regulatory requirements.
Plain-English summary
Innova Medical Group, Inc. is recalling its COVID-19 Self-Test Kit (model 3T) due to improper distribution. The affected test kits were distributed to customers who were not part of an authorized clinical investigation, violating FDA regulations governing medical device distribution.
The recall involves 402 boxes containing 1,206 tests (lot numbers U2102003 and X2012310). The kits were distributed nationwide throughout the United States, as well as to Canada, India, and the United Kingdom.
Consumers who have obtained these test kits should not use them. For additional information or guidance, contact Innova Medical Group or the FDA. This is classified as an FDA Class I recall, the agency's most serious classification for medical devices.
The recalled product
- Product
- COVID-19 Self-Test Kit *** INNOVA *** 3T
- Manufacturer
- INNOVA MEDICAL GROUP, INC.
- Category
- Medical Device — Diagnostic Test
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Catalog Number: 3T Lot Numbers: U2102003 X2012310
Distribution
Part of a larger recall action
This product is one of 3 recalled by INNOVA MEDICAL GROUP, INC. under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 3 products in this recall →Related recalls
Same manufacturer · INNOVA MEDICAL GROUP, INC.
See all →- SevereINNOVA SARS-CoV-2 Antigen Rapid Tests Recalled for Unauthorized Non-Clinical Distribution
FDA (Devices) · 2021-06-16
- SevereFDA Recalls Innova COVID-19 Self-Test Kits Due to Unauthorized Distribution
FDA (Devices) · 2021-06-16
Same hazard · unvalidated product
See all →- ModeratePrismatik Recalls BruxZir Shaded Dental Restorations Due to Quarantine Failure
FDA (Devices) · 2016-10-05
Similar recalls
- HighMatrix COVID-19 Test Kits Recalled for Unauthorized Home Sample Collection
FDA (Devices) · 2022-04-27
- HighCue Health COVID-19 Test Cartridge Recalled for Unapproved Distribution
FDA (Devices) · 2024-10-23
- SevereCOVID-19 Rapid Antigen Test Kits Recalled for Unauthorized Distribution
FDA (Devices) · 2022-05-18
- SevereCOVID-19 Rapid Antigen Test Kit Distributed Without FDA Approval
FDA (Devices) · 2022-02-09
- SevereCOVID-19 Test Kits Recalled for Unauthorized FDA Marketing and Sale
FDA (Devices) · 2022-02-09
- HighFDA Recalls Unauthorized COVID-19 Antigen Rapid Test Kits
FDA (Devices) · 2022-05-18